1. Home
  2. ALT vs VPG Comparison

ALT vs VPG Comparison

Compare ALT & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • VPG
  • Stock Information
  • Founded
  • ALT 1997
  • VPG 2009
  • Country
  • ALT United States
  • VPG United States
  • Employees
  • ALT N/A
  • VPG N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • VPG Electrical Products
  • Sector
  • ALT Health Care
  • VPG Technology
  • Exchange
  • ALT Nasdaq
  • VPG Nasdaq
  • Market Cap
  • ALT 292.0M
  • VPG 340.4M
  • IPO Year
  • ALT N/A
  • VPG N/A
  • Fundamental
  • Price
  • ALT $3.67
  • VPG $29.26
  • Analyst Decision
  • ALT Strong Buy
  • VPG
  • Analyst Count
  • ALT 6
  • VPG 0
  • Target Price
  • ALT $17.40
  • VPG N/A
  • AVG Volume (30 Days)
  • ALT 2.8M
  • VPG 105.8K
  • Earning Date
  • ALT 08-12-2025
  • VPG 08-05-2025
  • Dividend Yield
  • ALT N/A
  • VPG N/A
  • EPS Growth
  • ALT N/A
  • VPG N/A
  • EPS
  • ALT N/A
  • VPG N/A
  • Revenue
  • ALT $20,000.00
  • VPG $295,282,000.00
  • Revenue This Year
  • ALT N/A
  • VPG N/A
  • Revenue Next Year
  • ALT $761,880.20
  • VPG $5.48
  • P/E Ratio
  • ALT N/A
  • VPG N/A
  • Revenue Growth
  • ALT N/A
  • VPG N/A
  • 52 Week Low
  • ALT $2.90
  • VPG $18.57
  • 52 Week High
  • ALT $11.16
  • VPG $30.11
  • Technical
  • Relative Strength Index (RSI)
  • ALT 46.45
  • VPG 61.74
  • Support Level
  • ALT $3.35
  • VPG $28.22
  • Resistance Level
  • ALT $3.66
  • VPG $28.83
  • Average True Range (ATR)
  • ALT 0.18
  • VPG 0.89
  • MACD
  • ALT 0.05
  • VPG 0.20
  • Stochastic Oscillator
  • ALT 58.57
  • VPG 95.14

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

Share on Social Networks: